XM does not provide services to residents of the United States of America.

XM does not provide services to residents of the United States of America.
A
A

AMETEK

News

Reuters - 1 month ago

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Kellanova K.N +15.2% Tyson Foods Inc TSN.N +2.3% Advanced Micro Devices Inc AMD.OQ +2.1% Constellation Energy Corp CEG.OQ +2.0% AMETEK Inc AME.N +1.8% Bottom Performers Percent Change Intel Corp INTC.OQ -7.3% NVIDIA Corp NVDA.OQ -6.7%
I
K
N
W
A
U
A
Reuters - 2 months ago

U.S. Booking Holdings, Doordash, Vertex Pharmaceuticals

U.S. RESEARCH ROUNDUP- Booking Holdings, Doordash, Vertex Pharmaceuticals Aug 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Booking Holdings, Doordash and Vertex Pharmaceuticals, on Monday. HIGHLIGHTS * Academy Sports and Outdoors Inc ASO.O : JP Morgan cuts to neutral from overweight * Booking Holdings Inc BKNG.O : Jefferies cuts target price to $4350 from $4650 * Doordash DASH.O : D.A.
A
B
C
C
C
C
E
V
E
A
B
C
C
C
C
Reuters - 2 months ago

U.S. Apple, Centerpoint Energy, Cummins

U.S. RESEARCH ROUNDUP-Apple, Centerpoint Energy, Cummins Aug 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Apple, Centerpoint Energy and Cummins, on Friday. HIGHLIGHTS * Apple Inc AAPL.O : Wedbush raises target price to $285 from $275 * Centerpoint Energy CNP.N : JP Morgan cuts to neutral from overweight * Cummins CMI.N : Jefferies raises target price to $365 from $345 * Motorola MSI.N : JP Morgan raises target pr
A
A
B
B
I
K
M
A
B
C
A
A
A
A
C
C
L
M
Reuters - 2 months ago

AMETEK Inc reports results for the quarter ended in January - Earnings Summary

AMETEK Inc reports results for the quarter ended in January - Earnings Summary AMETEK Inc AME.N reported quarterly adjusted earnings of $1.66​​ per share for the quarter ended in January, higher than the same quarter last year, when the company reported EPS of $1.57. The mean expectation of thirteen analysts for the quarter was for earnings of $1.64 per share.
A
Reuters - 2 months ago

Ametek cuts 2024 profit forecast on slowing demand

Ametek cuts 2024 profit forecast on slowing demand Aug 1 (Reuters) - Industrial technology solutions provider Ametek AME.N cut its annual profit forecast on Thursday, as high borrowing costs and sticky inflation force its customers to delay project expenses. The company manufactures industrial solutions including testing and measurement instruments, medical devices and automation solutions.
A
Reuters - 2 months ago

AMETEK Q2 EPS USD 1.45

BRIEF-AMETEK Q2 EPS USD 1.45 Aug 01 (Reuters) - AMETEK Q2 sales USD 1,734.834 million vs. IBES estimate USD 1,784 million. Q2 operating income USD 447.514 million Q2 basic EPS USD 1.46 Q2 net income USD 337.683 million Q2 pretax profit USD 417.01 million
A
Reuters - 2 months ago

Fed nods to cut, chips rebound, BoE up next

MORNING BID AMERICAS-Fed nods to cut, chips rebound, BoE up next A look at the day ahead in U.S. and global markets from Mike Dolan The Federal Reserve left Wall Street with little doubt about a first U.S. interest rate cut in seven weeks' time, but multiple cross-currents from the earnings season , Japan and China, and domestic politics all make for a noisy start to August.
A
A
A
B
C
G
I
N
R
U
X
M
J
U
U
U
F
E
W
A
M
Reuters - 2 months ago

U.S. Booking Holdings, Doordash, Vertex Pharmaceuticals (Aug. 5)

CORRECTED-U.S. RESEARCH ROUNDUP-Booking Holdings, Doordash, Vertex Pharmaceuticals (Aug. 5) Corrects U.S. research roundup dated Aug. 5 to remove dated research actions from headline and tables, the errors appeared in previous versions also Aug 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Booking Holdings, Doordash and Vertex Pharmaceuticals, on Monday.
A
A
B
I
M
P
A
A
E
A
E
I
A
A
A
A
F
G
H
L
L
Reuters - 2 months ago

AMETEK Inc <AME.N> expected to post earnings of $1.64 a share - Earnings Preview

AMETEK Inc expected to post earnings of $1.64 a share - Earnings Preview AMETEK Inc AME.N , AME is expected to show a rise in quarterly revenue when it reports results on August 1 for the period ending January 1 0001 The Berwyn Pennsylvania-based company is expected to report a 8.4% increase in revenue to $1.784 billion from $1.65 billion a year ago, according to the mean estimate from 12 analysts, based on LSEG data.The company's guidance on May 2 2024, for the period ended June 30, was for rev
A
Reuters - 3 months ago

U.S. Atlassian, Crowdstrike Holdings, CS Disco

U.S. RESEARCH ROUNDUP-Atlassian, Crowdstrike Holdings, CS Disco July 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Atlassian, Crowdstrike Holdings and CS Disco, on Tuesday. HIGHLIGHTS * Atlassian Corp TEAM.O : Piper Sandler raises to overweight from neutral * Crowdstrike Holdings Inc CRWD.O : Piper Sandler cuts to neutral from overweight * CS Disco Inc LAW.N : JP Morgan cuts to underweight from neutral * Principa
C
C
C
N
P
W
A
C
A
F
L
P
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.